Pharmacological Activation of Group-II Metabotropic Glutamate Receptors Corrects a Schizophrenia-Like Phenotype Induced by Prenatal Stress in Mice

Brain-derived neurotrophic factor: findings in schizophrenia

(2011) Peter F Buckley et al.   CURRENT OPINION IN PSYCHIATRY

DNA methylation, the early-life social environment and behavioral disorders

(2011) Moshe Szyf   Journal of Neurodevelopmental Disorders

Maternal Influenza Viral Infection Causes Schizophrenia-Like Alterations of 5-HT2A and mGlu2 Receptors in the Adult Offspring

(2011) J. L. Moreno et al.   JOURNAL OF NEUROSCIENCE

Activation of Group II Metabotropic Glutamate Receptors Promotes DNA Demethylation in the Mouse Brain

(2011) F. Matrisciano et al.   MOLECULAR PHARMACOLOGY

Broad Epigenetic Signature of Maternal Care in the Brain of Adult Rats

(2011) Patrick O. McGowan et al.   PLoS One

Chronic agomelatine treatment corrects behavioral, cellular, and biochemical abnormalities induced by prenatal stress in rats

(2011) Sara Morley-Fletcher et al.   PSYCHOPHARMACOLOGY

Metabotropic Glutamate Receptors: Physiology, Pharmacology, and Disease

(2010) Colleen M. Niswender et al.   Annual Review of Pharmacology and Toxicology

From trans-methylation to cytosine methylation: Evolution of the methylation hypothesis of schizophrenia

(2010) Dennis R. Grayson et al.   Epigenetics

Metabotropic glutamate2/3 (mGlu2/3) receptors, schizophrenia and cognition

(2010) Gerard J. Marek   EUROPEAN JOURNAL OF PHARMACOLOGY

Effects of metabotropic glutamate receptor 2/3 agonism and antagonism on schizophrenia-like cognitive deficits induced by phencyclidine in rats

(2010) Nurith Amitai et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

The environment and schizophrenia

(2010) Jim van Os et al.   NATURE

Epigenetic regulation of the neural transcriptome: the meaning of the marks

(2010) Michael J Meaney et al.   NATURE NEUROSCIENCE

Epigenetic GABAergic targets in schizophrenia and bipolar disorder

(2010) A. Guidotti et al.   NEUROPHARMACOLOGY

Metabotropic glutamate receptors: From the workbench to the bedside

(2010) F. Nicoletti et al.   NEUROPHARMACOLOGY

The Role of Rodent Models in The Discovery of New Treatments for Schizophrenia: Updating Our Strategy

(2010) H. Moore   SCHIZOPHRENIA BULLETIN

Differential Expression of Metabotropic Glutamate Receptors 2 and 3 in Schizophrenia: A Mechanism for Antipsychotic Drug Action?

(2009) Subroto Ghose et al.   AMERICAN JOURNAL OF PSYCHIATRY

Epigenetic mechanisms in schizophrenia

(2009) Tania L. Roth et al.   BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS

Regulation of Group II Metabotropic Glutamate Receptors by G Protein-Coupled Receptor Kinases: mGlu2 Receptors Are Resistant to Homologous Desensitization

(2009) L. Iacovelli et al.   MOLECULAR PHARMACOLOGY

DTNBP1, NRG1, DAOA, DAO and GRM3 Polymorphisms and Schizophrenia: An Association Study

(2009) Erik G. Jönsson et al.   NEUROPSYCHOBIOLOGY

Group II metabotropic glutamate receptor activation by agonist LY379268 treatment increases the expression of brain derived neurotrophic factor in the mouse brain

(2009) V. Di Liberto et al.   NEUROSCIENCE

Candidate-gene association analysis of response to risperidone in African-American and white patients with schizophrenia

(2009) B A Fijal et al.   PHARMACOGENOMICS JOURNAL

Modeling the Positive Symptoms of Schizophrenia in Genetically Modified Mice: Pharmacology and Methodology Aspects

(2009) M. van den Buuse   SCHIZOPHRENIA BULLETIN

Neuronal Activity-Induced Gadd45b Promotes Epigenetic DNA Demethylation and Adult Neurogenesis

(2009) D. K. Ma et al.   SCIENCE

Schizophrenia: Moving Beyond Monoamine Antagonists

(2008) P. J. Conn et al.   MOLECULAR INTERVENTIONS

Identification of a serotonin/glutamate receptor complex implicated in psychosis

(2008) Javier González-Maeso et al.   NATURE

Brain-Derived Neurotropic Factor/TrkB Signaling in the Pathogenesis and Novel Pharmacotherapy of Schizophrenia

(2008) Anilkumar Pillai   NEUROSIGNALS

BDNFgene: functional Val66Met polymorphism in mood disorders and schizophrenia

(2008) Janusz K Rybakowski   PHARMACOGENOMICS

Prenatal Restraint Stress Generates Two Distinct Behavioral and Neurochemical Profiles in Male and Female Rats

(2008) Anna Rita Zuena et al.   PLoS One

Clozapine and sulpiride but not haloperidol or olanzapine activate brain DNA demethylation

(2008) E. Dong et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

MeCP2, a Key Contributor to Neurological Disease, Activates and Represses Transcription

(2008) M. Chahrour et al.   SCIENCE

Epigenetic programming of the stress response in male and female rats by prenatal restraint stress

(2007) Muriel Darnaudéry et al.   BRAIN RESEARCH REVIEWS